XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Changes in Equity (unaudited) - USD ($)
$ in Millions
Total
Total Baxter stockholders' equity
Common stock
Common stock in treasury
Additional contributed capital
Retained earnings
Accumulated other comprehensive income (loss)
Noncontrolling interests
Balance, beginning of period (in shares) at Dec. 31, 2021     683,000,000          
Balance, beginning of period (in usd) at Dec. 31, 2021 $ 9,121 $ 9,077 $ 683 $ (11,488) $ 6,197 $ 17,065 $ (3,380) $ 44
Balance, Treasury, beginning period (in shares) at Dec. 31, 2021       182,000,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) (2,606) (2,614)       (2,614)   8
Other comprehensive income (loss) (674) (674)         (674)  
Purchases of treasury stock (32) (32)   $ (32)        
Stock issued under employee benefit plans and other (in shares)       (3,000,000)        
Stock issued under employee benefit plans and other 214 214   $ 114 100      
Dividends declared on common stock (436) (436)       (436)    
Change in noncontrolling interests (8)             (8)
Balance, end of period (in shares) at Sep. 30, 2022     683,000,000          
Balance, end of period (in usd) at Sep. 30, 2022 5,579 5,535 $ 683 $ (11,406) 6,297 14,015 (4,054) 44
Balance, Treasury, ending period (in shares) at Sep. 30, 2022       179,000,000        
Balance, beginning of period (in shares) at Jun. 30, 2022     683,000,000          
Balance, beginning of period (in usd) at Jun. 30, 2022 8,903 8,859 $ 683 $ (11,409) 6,253 17,099 (3,767) 44
Balance, Treasury, beginning period (in shares) at Jun. 30, 2022       180,000,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) (2,934) (2,937)       (2,937)   3
Other comprehensive income (loss) (287) (287)         (287)  
Purchases of treasury stock (24) (24)   $ (24)        
Stock issued under employee benefit plans and other (in shares)       (1,000,000)        
Stock issued under employee benefit plans and other 71 71   $ 27 44      
Dividends declared on common stock (147) (147)       (147)    
Change in noncontrolling interests (3)             (3)
Balance, end of period (in shares) at Sep. 30, 2022     683,000,000          
Balance, end of period (in usd) at Sep. 30, 2022 5,579 5,535 $ 683 $ (11,406) 6,297 14,015 (4,054) 44
Balance, Treasury, ending period (in shares) at Sep. 30, 2022       179,000,000        
Balance, beginning of period (in shares) at Dec. 31, 2022     683,000,000          
Balance, beginning of period (in usd) at Dec. 31, 2022 $ 5,895 5,833 $ 683 $ (11,389) 6,322 14,050 (3,833) 62
Balance, Treasury, beginning period (in shares) at Dec. 31, 2022 179,062,594     179,000,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) $ 2,417 2,411       2,411   6
Other comprehensive income (loss) 117 117         117  
Stock issued under employee benefit plans and other (in shares)       (3,000,000)        
Stock issued under employee benefit plans and other 186 186   $ 140 46      
Dividends declared on common stock (446) (446)       (446)    
Change in noncontrolling interests (3)             (3)
Balance, end of period (in shares) at Sep. 30, 2023     683,000,000          
Balance, end of period (in usd) at Sep. 30, 2023 $ 8,166 8,101 $ 683 $ (11,249) 6,368 16,015 (3,716) 65
Balance, Treasury, ending period (in shares) at Sep. 30, 2023 176,198,622     176,000,000        
Balance, beginning of period (in shares) at Jun. 30, 2023     683,000,000          
Balance, beginning of period (in usd) at Jun. 30, 2023 $ 5,631 5,569 $ 683 $ (11,296) 6,341 13,655 (3,814) 62
Balance, Treasury, beginning period (in shares) at Jun. 30, 2023       177,000,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 2,511 2,508       2,508   3
Other comprehensive income (loss) 98 98         98  
Stock issued under employee benefit plans and other (in shares)       (1,000,000)        
Stock issued under employee benefit plans and other 74 74   $ 47 27      
Dividends declared on common stock (148) (148)       (148)    
Balance, end of period (in shares) at Sep. 30, 2023     683,000,000          
Balance, end of period (in usd) at Sep. 30, 2023 $ 8,166 $ 8,101 $ 683 $ (11,249) $ 6,368 $ 16,015 $ (3,716) $ 65
Balance, Treasury, ending period (in shares) at Sep. 30, 2023 176,198,622     176,000,000